CD BioSciences has launched centrosome antibody development services for cancer research
CD BioSciences, a biotech company specializing in centrosomal study, has recently launched new services for anti-centrosome antibody development. The services help identify and track centrosomes in experiments, demonstrating the strength of anti-centrosome antibodies as a great tool for...
Alfa Cytology has unveiled new services focused on therapeutic antibody development for bladder cancer research.
Alfa Cytology, a prominent cancer research services supplier based in New York, proudly announces the launch of its comprehensive services for bladder cancer therapeutic antibody development. This initiative represents a critical advancement in pursuing effective bladder...
Because of the inaccuracy and low efficiencies of traditional treatment, such as surgery, chemotherapy, and radiotherapy, in recent years, RDC (Radionuclide Drug Conjugate), with targeted diagnosis and imaging, has been widely noticed and studied in recent years.
The targeting biomolecules in RDC could be antibodies, small molecules, and peptides, in which antibodies are most commonly used,...
The global therapeutic sector is witnessing an unprecedented evolution, fueled by revolutionary advances in precision medicine and innovative treatment modalities. At the forefront of oncological breakthroughs stands the remarkable progression of Antibody Drug Conjugates (ADCs)—cutting-edge biopharmaceutical compounds that seamlessly integrate the targeted precision of monoclonal...
Trispecific antibodies are rapidly emerging as the next-generation modality in immunotherapy, offering a transformative approach to targeting cancer and other diseases. These engineered molecules can simultaneously interact with three different targets—whether antigens or immune cells—leading to improved specificity and enhanced therapeutic activity, particularly in oncology....
In the past few decades, both pharmaceutical companies and academia have spent much financial resources and energy to improve the practicability and accuracy of in vitro screening technology that can test the biological activity and physicochemical properties of compounds. However, the study of potential drug candidates in animal models remains disposable.
FDA, NMPA, and other regulatory...
The intricacies of the human immune system have been profoundly explored in recent years, revealing a wealth of knowledge that has unlocked new opportunities and methodologies for fighting diseases. One promising discovery is the concept of immune checkpoint therapy. The technology and mechanisms necessary for immune checkpoint antibody development have been under intense focus, which offers...
The COVID-19 pandemic, which emerged at the end of 2019, may have receded from public consciousness, but its impact continues to reverberate. Over the past three years, countries worldwide have grappled with multiple waves of widespread infection. Although many nations have now established immunity barriers, the risk of long COVID symptoms and recurrent infections still looms large. Such...
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the launch of new high-performance antibody pairs and antigens for the detection of human metapneumovirus (hMPV). These innovative products will advance scientists' capabilities and improve the accuracy and efficiency of hMPV diagnostics in research labs.
Human metapneumovirus, or...
Antibodies, the extraordinary proteins that serve as the frontline troops of the human immune system, have recently gained attention for their ability to combat tiny compounds known as haptens. Because of their small size, these elusive targets present particular difficulty for the immune system to identify as foreign invaders. However, researchers' inventiveness has resulted in the creation of...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek